Statin and aspirin for prevention of hepatocellular carcinoma: what are the levels of evidence?

  • Fabrice Carrat
  • Published 2014 in
    Clinics and research in hepatology and…

Abstract

Recent analyses of large cohorts suggest that statins or aspirin may reduce the risk of hepatocellular carcinoma (HCC). Due to their observational nature, these studies may have been flawed by confounding by indication or immortal time bias. Reviews of clinical trials conducted in the metabolic or cardiovascular domain showed no effect of statins on cancer… (More)
DOI: 10.1016/j.clinre.2013.09.007

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics